Many Americans think there will be a long-term effect on the nation's quality of life, employment and economic growth if U.S. lawmakers do not invest more in medical innovation, according to a survey from the Council for American Medical Innovation, or CAMI (PDF).
Many concerned about innovation: survey
The survey said 78% of respondents support providing government reforms to bring new innovations to market faster and at lower costs without compromising quality, while 81% said they support developing public-private partnerships among government, industry and universities to maximize resources and expertise in medical innovation and research. Meanwhile, 48% of those surveyed listed jobs and economic growth as the top reasons why it's important for the U.S. to be the global leader in innovation.
“My perception is that we are falling way behind in medical innovation,” former House Majority Leader Dick Gephardt (D-Mo.) said during a panel discussion at CAMI's symposium in Washington on Wednesday. Gephardt, who serves as the co-chairman of CAMI, said this is largely because the country has not had clear direction in the public and private sector. He also noted that the country's advancements in medical innovation will do more than create jobs and spur economic growth. “I believe that if we re-assert leadership in this area,” Gephardt said, “we will reduce healthcare costs dramatically.”
Panelist John Castellani, president and CEO of the Pharmaceutical Research and Manufacturers of America, said there should be appropriate reimbursement for innovation; incentive for research and development; and a regulatory process that protects patient safety and also speeds innovation.
The results came from a telephone survey of 1,009 adults ages 18 and older between Jan. 6-10, 2011.
Send us a letter